Upadacitinib is a pharmaceutical raw material that functions as a Janus kinase inhibitor. It is used in the manufacturing of medications that modulate inflammatory processes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1310726-60-3
Upadacitinib
pharmaceutical raw material
Upadacitinib hemihydrate
pharmaceutical raw material
Abrocitinib
pharmaceutical raw material
Peficitinib
pharmaceutical raw material
Baricitinib
pharmaceutical raw material
N-methyl-3-pyrrolidinyl cyclopentylmandelate
pharmaceutical raw material
2-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-3,3-diphenyl-2-propenoic Acid
pharmaceutical raw material
Erythromycin oxime
pharmaceutical raw material
(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
WYQFJHHDOKWSHR-MNOVXSKESA-N
CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F